This Indian drug would contain a toxic substance that becomes fatal in high doses.
The Indian maker of a cough syrup that killed 19 children in Uzbekistan has halted production after an inspection by the national drug control agency, India’s health minister and company Marion Biotech said on Friday.
Production at the plant in Noida, near New Delhi, has been halted since Thursday evening pending the inspection report, a senior Marion Biotech official said, while Health Minister Mansukh Mandaviya said investigations were continuing to determine the causes of these to identify health tragedies.
Neither Marion Biotech nor the Department of Health immediately responded to a Portal request for comment on news of non-compliance at one of the production lines. On Thursday, Uzbek media reported a 19. Victim of Doc-1 Max syrupa one year old child.
The Uzbek Health Ministry earlier said at least 18 children in Samarkand died after ingesting Marion Biotech syrup. According to the Ministry of Health, the drug contains a toxic substance, ethylene glycol, fatal in high doses. The little victim succumbed to one overdoseeither due to a mistake on the part of the parents who had not consulted a doctor or due to poor advice from pharmacists.
The Uzbek government has initiated one legal action against a representative of the Indian company in the country and instructed all pharmacies to withdraw syrups and tablets from Dok-1 Max. Another Indian pharmaceutical company, Maiden Pharmaceuticals Ltd. based in New Delhi, is implicated in a similar case: the deaths of at least 70 children are linked to cough syrup from its manufacture.